Given the fact that NK cells, as an important component of innate immunity, can also kill tumor cells via granzyme B secretion (34), we performed an in vivo depletion study to verify the contribution of granzyme B secreted by NK cells and CD8+ CTLs during immunotherapy (Figure 3, G and H). Here, CD8A is linked to neoplasm.